Ascendis Pharma A/S News

Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 17 19:08

Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 13 05:06

Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 12 05:05

Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 11 06:20

Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 11 06:10

Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 11 06:05

Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 11 06:00

Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 11 06:00

Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 11 05:59

Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 11 05:50

Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 4 05:41

Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 20 05:11

Ascendis Pharma A/S | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(16.1%),Peter Kolchinsky(16.1%), etc.

Nov 15 06:51

Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 15 05:59

Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 15 05:23

Ascendis Pharma A/S | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(7.0%)

Nov 15 04:02

Ascendis Pharma A/S | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. Rowe Price Investment Management, Inc.(2.9%)

Nov 15 02:34

Ascendis Pharma A/S | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(8.2%),Behzad Aghazadeh(8.2%)

Nov 14 22:36

Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Nov 14 05:10

Ascendis Pharma A/S | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Artisan Partners Limited Partnership(7.3%),Artisan Investments GP LLC(7.3%), etc.

Nov 12 22:55